167
Views
6
CrossRef citations to date
0
Altmetric
Research Article

Urinary lipid and protein oxidation products upon halothane, isoflurane, or sevoflurane anesthesia in humans: potential biomarkers for a subclinical nephrotoxicity

, , , &
Pages 73-81 | Received 17 Aug 2012, Accepted 02 Oct 2012, Published online: 09 Nov 2012
 

Abstract

Objective: To investigate whether lipid and protein oxidation products are elevated and correlated with routine clinical markers of hepatic and renal function in patients anesthetized with halothane, isoflurane, or sevoflurane.

Methods: Urine and blood samples were collected from patient groups. Excretion of aldehydes, acetone, and o,o’-dityrosine was measured before and after anesthesia. Blood samples were analysed for clinical markers.

Results: Urinary concentrations of aldehydes, acetone, o,o’-dityrosine and glucose were significantly increased after anesthesia in halothane and sevoflurane groups earlier than clinical markers. Significant correlations were found in sevoflurane group.

Conclusion: Lipid and protein oxidation contributes to subclinical sevoflurane nephrotoxicity. Oxidation products may serve as early biomarkers.

Acknowledgements

The Biochemistry Laboratory of Hacettepe University Hospitals is acknowledged for measuring clinical parameters except urinary protein and glucose.

Declaration of interest

Hilmi Orhan was supported with a grant of the Scientific and Technical Research Council of Turkey (TUBITAK-NATO A2) during the course of the study. The authors report no declaration of interests.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.